Physician profile
Eva Marshall
NPI 1477088342
$1,795.24
in general payments reported to CMS, 2019-2025
29 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $414 · 2023: $495 · 2024: $369 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $284.91 | 2021-2025 | |
| Astellas Pharma US INC | $175.91 | 2023-2024 | Veozah |
| Abbvie INC. | $153.67 | 2021-2023 | |
| Organon LLC | $143.61 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $142.47 | 2021-2025 | |
| Hologic Sales and Service, LLC | $106.64 | 2022-2025 | Thinprep 2000 Processor, Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Sage Therapeutics, LLC | $78.04 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $63.18 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $60.30 | 2022-2023 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $53.68 | 2022-2025 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $49.69 | 2022 | |
| Myovant Sciences INC. | $46.87 | 2021-2022 | |
| Medtronic, INC. | $46.13 | 2022 | |
| Baxter Healthcare | $45.97 | 2024 | Perclot |
| Shield Therapeutics INC | $41.98 | 2023-2024 | Accrufer |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $30.58 | 2024 | Senza |
| Daiichi Sankyo INC. | $28.24 | 2022 | |
| Teleflex LLC | $27.02 | 2025 | Quikclot |
| Sumitomo Pharma America, INC. | $24.30 | 2023 | Myfembree |
| Medicem INC. | $23.85 | 2023 | |
| Meditrina | $23.45 | 2024 | |
| Innovation Technologies INC | $22.49 | 2023 | Irrisept |
| Allergan, INC. | $21.59 | 2021 | |
| Cook Medical LLC | $21.57 | 2023 | Cook |
| Avion Pharmaceuticals | $17.95 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $17.22 | 2022 | |
| Gynesonics, INC. | $17.08 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Supernus Pharmaceuticals, INC. | $15.10 | 2025 | Qelbree |
| Dysis Medical, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.